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‘Human dignity is inviolable. To
respect and protect is the duty of
all state authority.’ Thus begins
the first article of the German
constitution, the ‘Grundgesetz’.
Many of the political debates of
the last decades, from abortion to
euthanasia, have been concerned
with the interpretation of the
concept of human dignity (‘Die
Würde des Menschen’ – in a more
literal translation: The dignity of
the human being): when does this
dignity begin and where does it
end? Does an 8-cell blastocyst
have human dignity, or a brain-
dead patient whose metabolism is
kept going by machines? Is the
production of embryonic stem
cells from blastocysts left over
after IVF treatment a violation of
human dignity? 
These questions are
fundamentally important for all
bioethics legislation in Germany,
because article 1 allows no
exception to the inviolability of
human dignity. While article 2,
which states the right to free
development and right to life,
keeps options open where the
fundamental rights of others are
affected (e.g. those of a woman
seeking abortion), there is
absolutely no messing with the
dignity of human beings
guaranteed by article 1. 
The current stem cell legislation,
passed in January 2002 by a
cross-party majority of biosceptic
backbenchers in the Bundestag, is
based on the assumption that
human dignity sets in when an egg
is fertilized, no matter whether this
happens in vivo or in vitro. As a
consequence, German
researchers are not allowed to
produce embryonic stem cells, or
even to collaborate with
researchers abroad who produce
them. They are only allowed to
import stem cell lines generated
before the first of January 2002,
provided they obtain specific
permission from an ethics council
based at the Robert Koch Institut
in Berlin. So far, the council has
granted only five such
permissions. 
While the scientific community
tends to disagree with the
constitutional protection of
undifferentiated cells as a matter
of principle, it has learned to live
with the current situation, which is
regarded as a compromise that
allows at least some research on
imported stem cell lines to
proceed over the next few years.
A truce had been established
between the sceptics who don’t
want any research based on
embryos, and researchers who
would ideally want to do a lot
more than they are allowed to
right now. 
At the end of October, this truce
was severely shaken by a speech
of the justice minister, Brigitte
Zypries (she replaced Herta
Däubler-Gmelin who had
mentioned Bush and Hitler in the
same sentence during the build-
up to the Iraq war). Even before
Zypries addressed her audience at
the Humboldt University, Berlin, a
version of her manuscript
circulated in media offices and
started to send out shockwaves.
The minister questioned whether
an artificially fertilized egg can
have human dignity. She argued
that an egg or blastocyst does not
per se have the ability to develop
into a human being, as it requires
the support of a woman willing to
carry the pregnancy to term. As
the state cannot force anybody to
do that, the pre-implantation
embryo has only a ‘perspective on
human dignity’ which can be
realized by a suitable woman, but
not by the state. 
Zypries made clear, however,
that the embryos in question have
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The UN postponement of its decision on human cloning brought relief to
stem cell researchers whose work may have been proscribed too. In
spite of the ethical hurdles a growing number of countries are seeking to
consider the potential in this field. Michael Gross reports.
Postponed: A potential UN-backed restriction on human stem cell research has been
delayed as an increasing number of countries are scrutinizing possible benefits from
allowing such work to go ahead. (Picture: Science Photo Library.)
the right of life as stated in article
2 of the constitution. Unlike the
right to human dignity, this right is
not absolute, and can be
balanced against other rights,
such as the freedom of
development of a potential
mother, and the freedom of
research. In a move to fence in
the predictable reactions of
religious critics, she also made
clear that she opposed
reproductive cloning and pre-
implantation diagnostics. 
Nevertheless, her speech
created the biggest upheaval in
the bioethics debate since the
stem cell law was passed. Going
beyond the usual exchange of
arguments between pro- and anti-
stem cell research fractions,
commentators soon pointed to
the tactical significance of the
surprise move. It is known that
Gerhard Schröder and the
relevant members of his
government are far from happy
with the limitations that the 2002
law imposes on biotechnology.
Research minister Edelgard
Bulmahn and health minister Ulla
Schmidt are known to support
Zypries’ interpretation. Wolfgang
Clement, Schröder’s ‘super-
minister’ for economics and
labour is so fervent a supporter of
stem cell research that — in his
previous function as head of a
regional government — he even
accompanied stem cell
researcher Oliver Brüstle on a trip
to Israel to foster research
collaboration. 
Thus, the unusual spectacle of
a justice minister distancing
herself from a law that is currently
in force, far from being ridiculed
as a faux-pas, was soon
described as ‘Schröder’s test
balloon,’ as the weekly news
magazine Der Spiegel put it. It
appears that the chancellor wants
to test whether the times are
ready for a correction of the
two-year-old stem cell law. After
all, there has been a general
election since the law was
passed, and the general
awareness of the potential
benefits of stem cell research has
been raised. Schröder, like many
analysts, probably realizes that
the time is not ripe yet for a more
permissive legislation, but he sent
out his minister to test out how
much longer he may have to wait. 
Meanwhile, his government
expresses its research-friendly
views on different fields far away
from its sceptical parliament and
population. This October, the
United Nations have revived
discussions of a possible
convention to ban cloning, which
had been started and then
abandoned without result a year
earlier. Over 40 countries,
including the USA, have
supported a proposal from Costa
Rica, which would instate a
comprehensive ban not only on
reproductive cloning, but also on
so-called therapeutic cloning, i.e.
generating replacement tissues
from embryonal stem cells. In
February, the German parliament
voted to demand that the foreign
office supports a UN convention
that bans both kinds of research. 
The German UN delegation,
however, has interpreted this
mandate loosely in that it
supports a two-step approach. It
argues that a ban on reproductive
cloning would easily find a broad
consensus in the UN, while the
question of therapeutic cloning
would divide the assembly.
Therefore, the German delegation
is not backing the Costa Rican
proposal, but the text proposed
by Belgium banning only
reproductive cloning and leaving
the other uses of human embryo
cells to national legislation. As a
number of countries including the
UK, Israel, and China are
rigorously opposed to a blanket
ban, the more restrictive proposal
was seen as unlikely to succeed in
any case. 
On November 6th, the legal
committee of the UN General
Assembly might have voted on the
Costa Rican proposal against the
Belgian one. The show-down was
averted, however, when the
committee accepted by a narrow
vote the proposal of Iran to defer
the decision on any convention
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Spanish Steps to stem cell research
Governments everywhere are struggling to keep up with the changes
in the science and bioethics of fertility and related issues. A
remarkably sensible solution to the stem cell question has now been
found in Spain. 
Fifteen years ago, Felipe González’s socialist government passed
what was then a progressive law regulating in vitro fertilization, the
Law of Assisted Reproduction (Ley de Reproducción Asistida). It
ordered the clinics to store left-over embryos from IVF treatments for
five years. As these left-over embryos started accumulating over the
years, a national commission recommended in 1998 to allow their use
for research, but the conservative government of José Maria Aznar’s
Partido Popular (PP) simply ignored that report. Only when a second
official report, delivered last February, came to the same conclusion,
the wheels of politics started moving. 
Health minister Ana Pastor recently stated that the number of
frozen IVF rejects in Spain is close to 200,000. Acknowledging that
these embryos cannot be kept frozen forever, the government drew
up a new legislation which essentially allows research – including
production of new stem cell lines – on the already existing embryos,
while blocking a similar build-up from happening in the future. When
the law, which passed parliament in October, comes into force at the
end of this year, both the IVF step and the implantation will be limited
to three eggs per cycle. If there are still any leftovers, they will have to
be kept for as long as the potential mother is biologically capable of
carrying them to term.
While the parliamentary opposition voted against the restrictions
on IVF procedures, it joined the scientific community in welcoming
the prospect of research using ‘old’ blastocysts. Ironically,
researchers in one of Europe’s most catholic and conservative
countries will soon be able to do research that is illegal in many
places including Germany and the United States.
against cloning by another two
years. By the autumn of 2005,
both the scientific and the political
context of such a convention may
be different. By then, the Bush
administration, which had acted
against the clear recommendation
of its National Academy may have
been replaced. And the German
government may have managed
to win the backing of its own
parliament in this important
question. 
The German government also
got a boost last month from a vote
in the European parliament to
allow European Union funds to be
spent on stem cell research in
spite of bitter opposition from
some campaign groups. The
move puts pressure on member
governments to free between 40
and 50 million euros for studies to
use cells from human embryos.
MEPs voted by 291 to 235 to
support new quality and safety
standards for ‘the manipulation of
tissues and cells’ after intense
lobbying by patient groups and
medical researchers.
The highly divisive issue split
the parliament down the middle
earlier this year. However the
landmark decision is not binding
and the last word will remain with
member states. They will
ultimately decide whether to lift a
moratorium that prevents cash
from Brussels being spent on
such experiments.
Sweden, Finland, Greece, the
Netherlands and Britain allow
harvesting stem cells from so-
called supernumerary embryos —
ones that are the result of in vitro
fertilization — under certain
conditions. Britain is the only EU
country at present that allows the
creation of embryos for stem cell
procurement.
Some Catholic countries such
as Italy, Portugal and Austria may
continue to oppose the proposals.
‘No country is forced to do
anything they believe is wrong but
ethical issues are matters for
national parliaments to decide,’
said David Bowe, a Labour MEP.
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The British government has made
a commitment to increase
spending on university research,
but the mechanisms by which it
assesses and allocates funds is
drawing increasing criticism from a
growing number of corners.
The UK’s leading science
academy has called on the
government to launch a
fundamental overhaul of university
research funding, warning that the
current system is burdensome,
outdated and in need of reform.
The Royal Society says that
universities are labouring under a
funding structure established three
decades ago in a ‘simpler and very
different world.’ The society
accuses the government of
tinkering with small-scale reviews
of research funding while failing to
examine the whole.
The key to the problem, it
argues, is the so-called dual
support system, under which
university research is funded
through research councils, which
fund direct project costs, and
through the higher education
funding councils, which distribute
infrastructure money.
Meeting the demands of both
strands burdens universities with
‘huge human and institutional
costs,’ says the society’s
president, Robert May.
An analysis put the cost of the
most recent research assessment
exercise, conducted periodically
since 1986 and used to share out
infrastructure funds, at £360
million. Academics say money
from the two funding sources are
distributed in broadly the same
way, despite requiring two
separate processes. ‘The time has
come to stop rearranging the deck
chairs on two entirely different
ships which ultimately have the
same direction,’ says May.
The Royal Society’s criticism
follows a report by the vice-
chancellors’ organization,
Universities UK, which attacked
government moves to concentrate
research funding in a few elite
universities. It argued the move led
to the loss of thousands of jobs
without improving the quality of
research. The substantial charitable
sector funding biomedical research
is also unhappy about suggestions
that funding from charities will not
be included as a factor in the
research assessment exercise. The
director of the Wellcome Trust, the
largest British research funding
charity, said: ‘This will reduce the
support received by many of the
UK’s most research-intensive
universities and move funds away
from biomedical sciences’.
‘It is the fundamental belief of
the Wellcome Trust that we fund
university research in partnership
with the government. We meet the
full direct costs of the work - the
costs of reagents and equipment,
and the salaries of technical staff
and many principal investigators.
But we expect research
environments — laboratories,
libraries, personnel departments
and so on — to be provided by the
government,’ says Walport. 
‘That is not to say that charities
should not contribute to indirect
costs. We have been enormous
contributors to infrastructure,
paying for buildings, staff and
equipment,’ he adds.
The combined assaults mean the
government faces criticism of the
proposed strategy on university
research and of the mechanism
required to fund it. Lord May also
criticizes the research assessment
exercise, saying it has become
more burdensome and bureau-
cratic. He said that, while initially it
proved effective in prompting a
flurry of long-postponed research,
it has now ‘been perverted by many
into a one-dimensional totem of the
prestige of a university department,
and ultimately of the institution
itself.’ He says the exercise ‘has
also promoted behaviours that play
to the rules of the game, which may
be different from those which serve
research excellence’.
‘Funding councils are between a
rock and a hard place. They do not
have enough money to sustain a
world-class science base. Such
sustainability will be reached only
through consistent investment
from government in partnership
with the charities,’ says Walport.
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Funding shake-up
urged
Britain’s system of funding
university research is under fire as
outdated. Nigel Williams reports.
